Qubit Pharmaceuticals
Develops AI- and quantum-enabled drug discovery tools and therapeutics for pharmaceutical partners and patients with major diseases
Highlights
- New on EvolcAdded 2026-10-29
About Qubit Pharmaceuticals
Qubit Pharmaceuticals develops drug candidates and molecular modeling technologies using quantum physics, computational chemistry and artificial intelligence. Its ATLAS platform supports molecular simulation, modeling and molecule generation.
The company pursues its own and partnered drug discovery programs, with a focus on oncology, inflammation and pandemic response, and offers joint discovery programs using ATLAS and its drug discovery team.
Founded in 2020, Qubit Pharmaceuticals is headquartered in Paris and also has offices in Boston and Chicago. Its team includes more than 60 employees, according to company materials.
Product: ATLAS molecular modeling platform and drug discovery programs for developing and optimizing drug candidates.
Jobs at Qubit Pharmaceuticals
More biotech & pharma companies
Roowin
Fine chemistry and cGMP drug-development services for pharmaceutical, biotechnology, and fine chemical companiesNew on EvolcScreencell
Patented CTC isolation kits that enrich circulating tumor cells from whole blood for cancer researchers and laboratoriesNew on EvolcSensorion
Biotechnology company developing therapies for people with hearing loss and inner ear disordersNew on EvolcSparingvision
Develops gene-agnostic gene therapies for patients with inherited retinal diseases and other blinding conditionsNew on EvolcSpartha Medical
Biopolymer coatings and testing services that help healthcare and cross-sector companies prevent microbial contaminationNew on EvolcSpore.Bio
AI-based, culture-free microbial detection device and consumables for quality control in factories, from pharma and beveragesYoung companyRemote-friendly
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Teamtailor
- Webflow